Tompkins Financial’s Organon & Co OGN Stock Holding History

Tompkins Financial’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.02K	Hold	75	–	–	﹤0.01%	531
2026 Q1	$449	Hold	75	–	–	﹤0.01%	550
2025 Q4	$538	Sell	75 -1	-1%	-$8	﹤0.01%	616
2025 Q3	$812	Sell	76 -25	-25%	-$245	﹤0.01%	524
2025 Q2	$978	Sell	101 -2,201	-96%	-$22.7K	﹤0.01%	523
2025 Q1	$34.3K	Sell	2,302 -85	-4%	-$1.31K	﹤0.01%	360
2024 Q4	$35.6K	Hold	2,387	–	–	﹤0.01%	349
2024 Q3	$45.7K	Sell	2,387 -25	-1%	-$518	﹤0.01%	350
2024 Q2	$49.9K	Hold	2,412	–	–	0.01%	340
2024 Q1	$45.3K	Buy	2,412 +1,974	+451%	+$33.9K	0.01%	361
2023 Q4	$6.32K	Buy	438 +41	+10%	+$558	﹤0.01%	529
2023 Q3	$6.89K	Buy	397 +19	+5%	+$396	﹤0.01%	494
2023 Q2	$7.87K	Hold	378	–	–	﹤0.01%	492
2023 Q1	$8.89K	Sell	378 -8	-2%	-$215	﹤0.01%	504
2022 Q4	$11K	Buy	386 +6	+2%	+$153	﹤0.01%	473
2022 Q3	$8K	Buy	380 +21	+6%	+$634	﹤0.01%	497
2022 Q2	$12K	Sell	359 -40	-10%	-$1.4K	﹤0.01%	456
2022 Q1	$14K	Buy	+399	New	+$13.6K	﹤0.01%	470

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Tompkins Financial's OGN Position: Q2 2026 in Review

Tompkins Financial held its Organon & Co (OGN) position steady in Q2 2026 at 75 shares worth $1.02K. The position accounts for ﹤0.01% of the portfolio, ranked #531.

Tompkins Financial first reported a position in OGN in Q1 2022 and has held it in 18 quarters since. The position peaked at $49.9K in Q2 2024. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Tompkins Financial held 75 shares of Organon & Co worth $1.02K as of Q2 2026.
Tompkins Financial left its Organon & Co share count unchanged in Q2 2026.
Organon & Co made up ﹤0.01% of Tompkins Financial's portfolio in Q2 2026, its #531 holding.
Tompkins Financial first reported a position in Organon & Co in Q1 2022 and has held it in 18 quarters since.
Tompkins Financial's Organon & Co position peaked at $49.9K in Q2 2024.
631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Tompkins Financial's 13F filing for Q2 2026, filed 15 Jul 2026.